Document center

A hand picked selection of interesting presentations and info

Assessing the Influence of ERC-funded Research on Patented Inventions – Final report

Published on | 1 year ago

Programmes ERC ERC

The report is based on data retrieved from 6,671 ERC-funded projects from all scientific domains, including all projects funded from 2007 until 2014 (7th Framework Programme - FP7) and part of Horizon 2020 - H2020). The study attempted to answer the question how and to what extent the discoveries described by ERC grantees in scientific publications inspired new technologies presented in patent applications, which were filed by firms and institutions all over the world. A summary of the findings can be found in the executive summary of main findings in the report (p.4-6) and this ERC press release.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.